• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
Hong Kong-listed biotechnology stocks continued to rise in the afternoon, with Transcenta Pharmaceuticals (06628.HK) surging more than 36%, Coherus Biopharma (02171.HK) surging more than 23%, Beihai Kangcheng (01228.HK) and CASI Biopharma (01167.HK) both rising more than 19%, InnoCare Pharma (09969.HK) and Junshi Biosciences (01877.HK) all rising more than 12%.On February 26, Hong Kong SAR Government Financial Secretary Paul Chan said today (26th) that the SAR government will study the collection of border construction fees from private cars leaving the land border control station, and tourist buses and trucks will not be affected. If each private car is charged HK$200, it can bring in about HK$1 billion in revenue each year. ​​​Futures news on February 26, Economies.com analysts latest views today: Spot gold faces additional negative pressure, confirming a break below the support line of the rising channel, turning to an intraday bearish correction, with the target of testing 2868.80 as the next target, which represents the 23.6% Fibonacci retracement level from 2583.75 to 2956.90.Futures February 26th, Economies.com analysts latest views today: After experiencing a sharp drop in the previous few transactions, WTI crude oil futures prices noticed that the price resumed the main downward trend within the bearish channel shown on the chart, which supports the possibility of continued declines within the day and in the short term, and is expected to achieve further declines.Futures February 26, Economies.com analysts latest views today: Brent crude oil futures prices fell strongly yesterday, breaking below the 74.00 level, and continued to fall within the bearish channel shown on the chart, supported by the negative pressure formed by EMA50.

AUD/JPY bulls cheer China-inspired optimism; Japan data near 89.50 are mixed

Daniel Rogers

Dec 27, 2022 11:12

 AUD:JPY.png

 

The AUD/JPY pair creeps higher around 89.50 as bulls capitalize on the cautious Christmas market optimism. In doing so, despite the most recent dip, the cross-currency pair extends Friday's gains to hit weekly highs.

 

Nonetheless, the price increase may be linked to the risk-on market mentality, which was mostly driven by China, as well as lowering expectations of hawkish actions by the Bank of Japan (BOJ).

 

As on January 8, China no longer requires inbound travelers to undergo COVID quarantine. In addition to geopolitical concerns from Russia and North Korea, the news contributed to the market's cautious optimism. S&P 500 Futures advance intraday by 0.60 percent to 3,892, while 10-year US Treasury rates remain slow at roughly 3.74% as of press time.

 

After the central bank adjusted monetary policy last week, Governor Haruhiko Kuroda and Prime Minister Fumio Kishida of the Bank of Japan (BOJ) and Prime Minister of Japan (PM) Fumio Kishida, respectively, attempted to calm hawkish expectations. According to Kuroda of the BOJ, however, the broadening of the yield band is not a forerunner to an easy policy exit. In a similar spirit, Japanese Prime Minister Kishida ruled out the BOJ and government amending the central bank statement.

 

In terms of the facts, Japan's Unemployment Rate declined to 3.5% in November compared to the 3.6% predicted previously, while the Jobs / Applicants Ratio for the same month was 1.35 compared to the market prediction of 1.35. In addition, year-over-year growth in Retail Trade fell to 2.6% from 2.8% anticipated and 4.0% earlier.

 

A quiet schedule ahead of Saturday's official China PMIs and year-end market inaction will restrict AUD/JPY movement moving forward.